Jinjian Yang

887 total citations
27 papers, 407 citations indexed

About

Jinjian Yang is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Jinjian Yang has authored 27 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jinjian Yang's work include MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Jinjian Yang is often cited by papers focused on MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Jinjian Yang collaborates with scholars based in China, United States and Germany. Jinjian Yang's co-authors include Zhankui Jia, Chaohui Gu, Zhibo Jin, Zhengguo Zhang, Yiming Zhang, Yu Zhang, Fengyan Tian, Yanbin Guan, Ke Sun and Ranran Duan and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and PLoS Pathogens.

In The Last Decade

Jinjian Yang

26 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinjian Yang China 12 280 166 58 57 40 27 407
Dan Hu China 13 359 1.3× 260 1.6× 82 1.4× 49 0.9× 34 0.8× 31 519
Chuan Wang China 13 344 1.2× 207 1.2× 47 0.8× 32 0.6× 38 0.9× 35 479
Chenfeng Wang China 13 259 0.9× 144 0.9× 70 1.2× 58 1.0× 41 1.0× 25 387
Elena Jamali Iran 11 356 1.3× 229 1.4× 75 1.3× 39 0.7× 36 0.9× 54 510
Yulong Bao China 6 199 0.7× 108 0.7× 53 0.9× 69 1.2× 36 0.9× 11 305
Ji Chen China 10 312 1.1× 208 1.3× 80 1.4× 45 0.8× 70 1.8× 19 439

Countries citing papers authored by Jinjian Yang

Since Specialization
Citations

This map shows the geographic impact of Jinjian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjian Yang more than expected).

Fields of papers citing papers by Jinjian Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjian Yang. The network helps show where Jinjian Yang may publish in the future.

Co-authorship network of co-authors of Jinjian Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinjian Yang. A scholar is included among the top collaborators of Jinjian Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinjian Yang. Jinjian Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Ruoyang, Long Zhang, Xiang Li, et al.. (2025). Docetaxel induced activation of GSDME pathway and pyroptosis enhance immune lethality in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 45(1). 22–22.
2.
Li, Ningyang, Yating Xu, Liang Yu, et al.. (2024). Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway. Cell Death and Disease. 15(9). 665–665. 2 indexed citations
3.
Song, Liang, Ruoyang Liu, Yu Zhang, et al.. (2024). 8-Br-cGMP activates HSPB6 and increases the antineoplastic activity of quinidine in prostate cancer. Cell Death Discovery. 10(1). 90–90. 3 indexed citations
4.
Zhang, Yu, Congwei Wang, Zhankui Jia, et al.. (2024). Exosomes derived from bladder epithelial cells infected with uropathogenic Escherichia coli increase the severity of urinary tract infections (UTIs) by impairing macrophage function. PLoS Pathogens. 20(1). e1011926–e1011926. 10 indexed citations
5.
Song, Liang, Ningyang Li, Xiang Li, et al.. (2024). PDE3B regulates KRT6B and increases the sensitivity of bladder cancer cells to copper ionophores. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(7). 4911–4925. 8 indexed citations
6.
Huang, Lu, Hui Dong, Zhi Yang, et al.. (2023). [Association between volatile organic compounds and mortality risk of stroke].. PubMed. 44(8). 1216–1223. 1 indexed citations
7.
Li, Xiang, Bo Tang, Hao Li, et al.. (2023). SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors. Cancer Research. 83(6). 875–889. 23 indexed citations
8.
Tang, Bo, Yinhui Yang, Zhaogang Yang, et al.. (2021). MAP3K7-IKK Inflammatory Signaling Modulates AR Protein Degradation and Prostate Cancer Progression. Cancer Research. 81(17). 4471–4484. 11 indexed citations
9.
Zhang, Wenhui, Tao Wang, Yan Wang, et al.. (2021). Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis. Translational Oncology. 16. 101311–101311. 8 indexed citations
10.
11.
Sun, Ke, et al.. (2019). Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma. Biochemical and Biophysical Research Communications. 510(3). 416–420. 48 indexed citations
12.
Wang, Hui, Jinjian Yang, Shiwen Li, et al.. (2018). LncRNA MIAT facilitated BM-MSCs differentiation into endothelial cells and restored erectile dysfunction via targeting miR-200a in a rat model of erectile dysfunction. European Journal of Cell Biology. 97(3). 180–189. 27 indexed citations
13.
Li, Songchao, et al.. (2018). Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1. Cell & Bioscience. 8(1). 9–9. 33 indexed citations
14.
Xu, Hailiang, Zhankui Jia, Jinjian Yang, et al.. (2017). AXIN1 protects against testicular germ cell tumors via the PI3K/AKT/mTOR signaling pathway. Oncology Letters. 14(1). 981–986. 11 indexed citations
15.
Li, Fujun, et al.. (2016). miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression. Oncology Reports. 35(5). 2859–2865. 27 indexed citations
16.
Xue, Rui, et al.. (2015). High-mobility group box 1 is involved in the development of benign prostatic hyperplasia with chronic prostatic inflammation. Scandinavian Journal of Urology. 49(6). 479–485. 2 indexed citations
17.
Jia, Zhankui, Rui Xue, Gangqiong Liu, et al.. (2014). HMGB1 Is Involved in the Protective Effect of the PPARαAgonist Fenofibrate against Cardiac Hypertrophy. PPAR Research. 2014. 1–9. 27 indexed citations
18.
Guan, Yanbin, et al.. (2014). Chloride Intracellular Channel 1 Regulates Prostate Cancer Cell Proliferation and Migration Through the MAPK/ERK Pathway. Cancer Biotherapy and Radiopharmaceuticals. 29(8). 339–344. 42 indexed citations
19.
Tian, Fengyan, Jiarui Pu, Liduan Zheng, et al.. (2014). Over-expression of testis-specific expressed gene 1 attenuates the proliferation and induces apoptosis of GC-1spg cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 34(4). 535–541. 3 indexed citations
20.
Xue, Rui, et al.. (2013). HMGB1: A potential target for treatment of benign prostatic hyperplasia. Medical Hypotheses. 81(5). 892–895. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dan Hu Breakdown of academic impact, for papers by Chuan Wang Breakdown of academic impact, for papers by Chenfeng Wang Breakdown of academic impact, for papers by Elena Jamali Breakdown of academic impact, for papers by Yulong Bao Breakdown of academic impact, for papers by Ji Chen
Rankless by CCL
2026